Elevated serum IL-17 A and CCL20 levels as potential biomarkers in major psychotic disorders: a case-control study

Parisa Ghasemi Noghabi,Najmeh Shahini,Zanireh Salimi,Somayeh Ghorbani,Yasser Bagheri,Firoozeh Derakhshanpour
DOI: https://doi.org/10.1186/s12888-024-06032-3
IF: 4.144
2024-10-12
BMC Psychiatry
Abstract:Major psychotic disorders (MPD), including schizophrenia (SCZ) and schizoaffective disorder (SAD), are severe neuropsychiatric conditions with unclear causes. Understanding their pathophysiology is essential for better diagnosis, treatment, and prognosis. Recent research highlights the role of inflammation and the immune system, particularly the Interleukin 17 (IL-17) family, in these disorders. Elevated IL-17 levels have been found in MPD, and human IL-17 A antibodies are available. Changes in chemokine levels, such as CCL20, are also noted in SCZ. This study investigates the relationship between serum levels of IL-17 A and CCL20 in MPD patients and their clinical characteristics.
psychiatry
What problem does this paper attempt to address?